Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $46.89 million. The enterprise value is $35.12 million.

Market Cap	46.89M
Enterprise Value	35.12M

Important Dates

The last earnings date was Tuesday, May 14, 2024, before market open.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

GANX has 18.05 million shares outstanding. The number of shares has increased by 50.64% in one year.

Shares Outstanding	18.05M
Shares Change (YoY)	+50.64%
Shares Change (QoQ)	+19.71%
Owned by Insiders (%)	6.76%
Owned by Institutions (%)	14.33%
Float	16.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	170.26
PB Ratio	5.43
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.10.

Current Ratio	2.77
Quick Ratio	n/a
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -213.30% and return on invested capital (ROIC) is -224.53%.

Return on Equity (ROE)	-213.30%
Return on Assets (ROA)	-129.00%
Return on Capital (ROIC)	-224.53%
Revenue Per Employee	n/a
Profits Per Employee	-$729,117
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $82,421 in taxes.

Income Tax	82,421
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.71% in the last 52 weeks. The beta is 0.53, so GANX's price volatility has been lower than the market average.

Beta (1Y)	0.53
52-Week Price Change	-47.71%
50-Day Moving Average	3.43
200-Day Moving Average	3.40
Relative Strength Index (RSI)	37.63
Average Volume (30 Days)	122,420

Short Selling Information

The latest short interest is 154,195, so 0.85% of the outstanding shares have been sold short.

Short Interest	154,195
Short Previous Month	149,596
Short % of Shares Out	0.85%
Short % of Float	0.92%
Short Ratio (days to cover)	1.66

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.40M
Pretax Income	-21.06M
Net Income	-21.14M
EBITDA	-20.98M
EBIT	-21.06M
Earnings Per Share (EPS)	-$1.50

Full Income Statement

Balance Sheet

The company has $12.66 million in cash and $889,618 in debt, giving a net cash position of $11.77 million or $0.65 per share.

Cash & Cash Equivalents	12.66M
Total Debt	889,618
Net Cash	11.77M
Net Cash Per Share	$0.65
Equity / Book Value	8.64M
Book Value Per Share	0.48
Working Capital	8.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.24 million and capital expenditures -$4,313, giving a free cash flow of -$18.24 million.

Operating Cash Flow	-18.24M
Capital Expenditures	-4,313
Free Cash Flow	-18.24M
FCF Per Share	-$1.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.64%
Shareholder Yield	-50.64%
Earnings Yield	-45.09%
FCF Yield	-38.90%

Analyst Forecast

The average price target for GANX is $8.50, which is 223.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	223.19%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	292.11%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2